MDxHealth

Foundation date

2003

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

MDxHealth is a molecular diagnostics company committed to developing novel, accurate, and informative diagnostic tests for early detection of cancer and for personalizing cancer treatment decisions.

Upcoming events

Latest news

  • Mithra announces topline results for COVID-19 Phase II Study

    1 day ago

  • Biocartis announces restart of its high-throughput cartridge manufacturing line

    Thursday September 23rd 2021

  • Rewind Therapeutics appoints Anja Harmeier, PhD, MBA, as Chief Executive Officer

    Wednesday September 22nd 2021